Neurologist-Led Management of Implantable Loop-Recorders After Embolic Stroke of Undetermined Source.
PQ interval
atrial fibrillation
embolic stroke of undetermined source
ischemic stroke (IS)
loop recorder
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
11
2021
accepted:
27
12
2021
entrez:
14
2
2022
pubmed:
15
2
2022
medline:
15
2
2022
Statut:
epublish
Résumé
Upon completion of the workup for stroke, etiology cannot be identified in approximately one-third of the patients, with an embolic stroke of undetermined source (ESUS) accounting for around 50% of these cryptogenic etiologies. Whether management of complex long-term monitoring in order to detect suspected atrial fibrillation (AFib) could be initiated and managed through a neurologist is not sufficiently investigated. We recruited all consecutive patients with ESUS who received implantation after neurological adjudication of Reveal LINQ We followed a total of 131 patients for a median of 504 days. There were 45 (34%) manually verified AFib diagnoses. In univariate analysis, earlier implantation after ESUS was associated with AFib detection (13 vs. 31 days, We observed similar predictors for Afib after ESUS, albeit with higher frequency than previously reported. This study suggests that the neurologist-led decision, management, and evaluation of ILR after ESUS is feasible.
Identifiants
pubmed: 35153991
doi: 10.3389/fneur.2021.816511
pmc: PMC8831881
doi:
Types de publication
Journal Article
Langues
eng
Pagination
816511Informations de copyright
Copyright © 2022 Pikija, Rösler, Leitner, Zellner, Bubel, Ganser, Hecker and Mutzenbach.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Circulation. 2010 May 4;121(17):1904-11
pubmed: 20404258
Neurology. 2016 Jan 19;86(3):261-9
pubmed: 26683642
Int J Stroke. 2019 Feb;14(2):207-214
pubmed: 30196789
Heart Rhythm. 2020 Jan;17(1):75-80
pubmed: 31323348
Stroke. 2001 Jun;32(6):1318-22
pubmed: 11387493
Am J Cardiol. 2017 Feb 1;119(3):466-472
pubmed: 27889043
Stroke. 2019 Aug;50(8):1997-2001
pubmed: 31189435
Stroke. 2021 Jul;52(7):e364-e467
pubmed: 34024117
N Engl J Med. 2012 Jan 12;366(2):120-9
pubmed: 22236222
Lancet. 2009 Feb 28;373(9665):739-45
pubmed: 19249635
N Engl J Med. 2018 Jun 07;378(23):2191-2201
pubmed: 29766772
Am J Cardiol. 2013 Jun 1;111(11):1602-7
pubmed: 23499279
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Lancet. 2016 Aug 20;388(10046):761-75
pubmed: 27431356
Am J Med. 2016 Aug;129(8):843-9
pubmed: 27012854
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Ann Intern Med. 2013 Dec 3;159(11):721-8
pubmed: 24297188
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
Cerebrovasc Dis. 2020;49(3):285-291
pubmed: 32554958
JAMA. 2021 Jun 1;325(21):2160-2168
pubmed: 34061146
JAMA. 2009 Jun 24;301(24):2571-7
pubmed: 19549974
Am J Cardiol. 2011 Mar 15;107(6):917-921.e1
pubmed: 21255761
J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2448-2452
pubmed: 31307898
Heart. 2017 Aug;103(16):1271-1277
pubmed: 28255099
Neurology. 2013 Apr 23;80(17):1546-50
pubmed: 23535493
Thromb Haemost. 2017 Oct 5;117(10):1962-1969
pubmed: 28862284
J Atr Fibrillation. 2018 Oct 31;11(3):2078
pubmed: 31139276
Cerebrovasc Dis. 2021;50(1):46-53
pubmed: 33311022